Evidence map›Paper›PMID 28791312›Full record

ArticleJournal of immunology research2017

Synergistic Antitumour Properties of

Rahel Mascha Stammer, Susann Kleinsimon, Jana Rolff, Sebastian Jäger, Angelika Eggert, Georg Seifert, Catharina I Delebinski

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05726383 (MISTOSUS), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05726383 phase2recruitingnot on this mapstarted 2024, after this paper: background citation

MISTOSUS: Iscador® P (Mistletoe) Immunotherapy To Improve Event Free Survival In Patients With Relapsed Resectable Osteosarcoma

TypeinterventionalSponsorHackensack Meridian HealthRan2024 to 2027Enrolled32ConditionsOsteogenic Sarcoma RecurrentArmsIscador*P
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. MISTOSUS: a phase II trial ofFuture oncology (London, England) · 2026
    Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Rahel Mascha StammerDepartment of Paediatric Oncology/Haematology, Otto-Heubner Centre for Paediatric and Adolescent Medicine (OHC), Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Susann KleinsimonDepartment of Paediatric Oncology/Haematology, Otto-Heubner Centre for Paediatric and Adolescent Medicine (OHC), Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.ORCID 0000-0003-0989-8171
Jana RolffEPO GmbH, Experimental Pharmacology & Oncology, Robert-Rössle-Str. 10, 13125 Berlin-Buch, Germany.ORCID 0000-0002-2364-3274
Sebastian JägerBirken AG, Streiflingsweg 11, 75223 Niefern-Öschelbronn, Germany.
Angelika EggertDepartment of Paediatric Oncology/Haematology, Otto-Heubner Centre for Paediatric and Adolescent Medicine (OHC), Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Georg SeifertDepartment of Paediatric Oncology/Haematology, Otto-Heubner Centre for Paediatric and Adolescent Medicine (OHC), Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.ORCID 0000-0002-7109-9277
Catharina I DelebinskiDepartment of Paediatric Oncology/Haematology, Otto-Heubner Centre for Paediatric and Adolescent Medicine (OHC), Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.ORCID 0000-0003-2527-4385
Charité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aqueous mistletoe extracts from the European mistletoe (

Indexed as

AdolescentAnimalsAntineoplastic Agents, PhytogenicApoptosisCell ProliferationChildDrug SynergismFemaleHumansMaleMicePhytotherapyPlant ExtractsRhabdomyosarcoma, AlveolarTumor Cells, CulturedViscum albumAntineoplastic Agents, PhytogenicPlant Extracts

Identifiers

PMID28791312
PMCPMC5534308
OpenAlexW2734413394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.